• No results found

Arterial hypertension (AH)

Environmental and Occupational Risk Factors Effect to Arterial Hypertension: Correlation between Arterial  Hypertension and Lead

Environmental and Occupational Risk Factors Effect to Arterial Hypertension: Correlation between Arterial Hypertension and Lead

... for hypertension include smoking, the consumption of alcohol, poor dietary habits, lack of exercise, and ...for hypertension. The goal is to assess the correlation of lead to arterial ...

6

Molecular pathogenesis of pulmonary arterial hypertension

Molecular pathogenesis of pulmonary arterial hypertension

... Pulmonary arterial hypertension (PAH) is diagnosed by an eleva- tion in mean pulmonary arterial (PA) pressure above 25 mmHg at rest or 30 mmHg with ...Pulmonary Hypertension in Dana Point, ...

9

Ambrisentan for the treatment of pulmonary arterial hypertension

Ambrisentan for the treatment of pulmonary arterial hypertension

... Pulmonary arterial hypertension (PAH) is a disease of the small pulmonary arteries that is characterized by vasoconstriction and vascular remodeling (Humbert et al ...

16

Risk assessment in pulmonary arterial hypertension

Risk assessment in pulmonary arterial hypertension

... pulmonary arterial hypertension ...pulmonary hypertension (PH) guidelines, and the application of risk equations and scores, such as the French registry risk equation and the REVEAL registry risk ...

9

Health education in territory: systemic arterial hypertension

Health education in territory: systemic arterial hypertension

... and the social factors involved. In this situation, the Ministry of Health advocate for lifestyle changes, which are fundamental in the therapeutic process and prevention of hypertension. A proper alimentation, ...

6

Pregnancy in pulmonary arterial hypertension

Pregnancy in pulmonary arterial hypertension

... pulmonary arterial hypertension (PAH) remains high in pregnancy and is especially high during the post-partum ...pulmonary hypertension centres with experience in managing PAH during and after ...

7

Exertional dyspnoea in pulmonary arterial hypertension

Exertional dyspnoea in pulmonary arterial hypertension

... ABSTRACT Dyspnoea is a principal presenting symptom in pulmonary arterial hypertension (PAH), and often the most distressing. The pathophysiology of PAH is relatively well understood, with the primary ...

9

Novel biomarkers for pulmonary arterial hypertension

Novel biomarkers for pulmonary arterial hypertension

... Pulmonary arterial hypertension is a deadly disease characterized by elevated pulmonary arterial pressures leading to right ventricular hypertrophy and ...

10

Trends in pulmonary arterial hypertension

Trends in pulmonary arterial hypertension

... pulmonary arterial hyper- tension management and the perspectives that are now ...pulmonary arterial hypertension, tend to ...pulmonary arterial hypertension will be more ...

6

An AMPK paradox in pulmonary arterial hypertension

An AMPK paradox in pulmonary arterial hypertension

... Adenosine monophosphate-activated protein kinase (AMPK) is a heterotrimeric serine-threonine kinase important as a metabolic sensor for intracellular ATP levels and plays a key role in regulating cell survival and ...

5

Arterial Hypertension in Hemodialysis Patients

Arterial Hypertension in Hemodialysis Patients

... that arterial hypertension is common among hemodialysis ...systolic hypertension was ...intradialytic hypertension, so blood pressure values were increased during hemodialysis and that ...

5

Autonomic nervous system involvement in pulmonary arterial hypertension

Autonomic nervous system involvement in pulmonary arterial hypertension

... Pulmonary arterial hypertension (PAH) is a chronic pulmonary vascular disease characterized by increased pulmonary vascular resistance (PVR) leading to right ventricular (RV) ...pulmonary ...

15

Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology

Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology

... pulmonary hypertension (PH) was recently updated at the 4th World Symposium on Pulmonary Hypertension ...pulmonary arterial hypertension (PAH); pulmonary veno-occlusive disease and/or pulmo- ...

5

Counter-clockwise vortical blood flow in the main pulmonary artery in a patient with patent ductus arteriosus with pulmonary arterial hypertension: a cardiac magnetic resonance imaging case report

Counter-clockwise vortical blood flow in the main pulmonary artery in a patient with patent ductus arteriosus with pulmonary arterial hypertension: a cardiac magnetic resonance imaging case report

... Pulmonary arterial hypertension (PAH) is a complica- tion in patients with patent ductus arteriosus (PDA), and the retrograde blood flow in the main pulmonary artery caused by left-to-right shunting via the ...

5

Arterial hypertension in the worsening clinical condition of dengue

Arterial hypertension in the worsening clinical condition of dengue

... systemic arterial hypertension are more likely to develop dengue hemorrhagic ...systemic arterial hypertension present with suspected dengue, they should be stratified into the group most ...

5

The right ventricle in pulmonary arterial hypertension

The right ventricle in pulmonary arterial hypertension

... ABSTRACT Pulmonary arterial hypertension (PAH) is a right heart failure syndrome. In early-stage PAH, the right ventricle tends to remain adapted to afterload with increased contractility and little or no ...

12

Future perspectives in pulmonary arterial hypertension

Future perspectives in pulmonary arterial hypertension

... Pulmonary arterial hypertension (PAH) has evolved from a disease with limited treatment options to one where numerous therapies that target three key pathophysiological pathways in the disease ...

9

Platelet derived growth factor receptor β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno occlusive disease

Platelet derived growth factor receptor β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno occlusive disease: a case control study

... Systemic sclerosis (SSc) is an autoimmune disease char- acterized by dysfunction of endothelium, an altered immune tolerance and the deposition of excessive amounts of extra-cellular matrix components in multi- ple organ ...

13

Inhaled treprostinil and pulmonary arterial hypertension

Inhaled treprostinil and pulmonary arterial hypertension

... of PAH caused by mutations in bone morphogenic protein receptor-2 or activin-like kinase 1 represented only 2.7% of cases. Other etiologies of PAH include those associated with connective tissue disorders (25.3%), ...

10

Macitentan for the treatment of pulmonary arterial hypertension

Macitentan for the treatment of pulmonary arterial hypertension

... pulmonary arterial hypertension patients with macitentan led to statistically significant improvements in functional class, exercise tolerance, and hemodynamic parameters, in addition to a reduction in ...

9

Show all 8656 documents...

Related subjects